Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Preventing severe COVID-19 infection in patients with CLL

Yair Herishanu • 7 Oct 2022
ERIC 2022
Chronic Lymphocytic Leukemia Leukemia Antibodies

Yair Herishanu, MD, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, comments on the management of patients with chronic lymphocytic leukemia (CLL) to prevent severe infection with COVID-19, highlighting the importance of immunization and prophylaxis. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Yair Herishanu

1:50
Responses to COVID-19 vaccination in patients with CLL
Yair Herishanu • 7 Oct 2022

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals